Advertisement
Advertisement
EHAB
Enhabit, Inc.
13.79
USDSponsored
+0.01
+0.04%
May 11, 09:31 UTC -4
Open
EHAB Earnings Reports
Positive Surprise Ratio
EHAB beat 7 of 14 last estimates.
50%
Next Report
In 2 Days
Date of Next Report
May 13, 2026
Estimate for Q1 26 (Revenue/ EPS)
$271.14M
/$0.15
Implied change from Q4 25 (Revenue/ EPS)
+0.27%
/+7.14%
Implied change from Q1 25 (Revenue/ EPS)
+4.33%
/+50.00%
Enhabit, Inc. earnings per share and revenue
On Mar 04, 2026, EHAB reported earnings of 0.14 USD per share (EPS) for Q4 25, missing the estimate of 0.14 USD, resulting in a -3.11% surprise. Revenue reached 270.40 million, compared to an expected 275.97 million, with a -2.02% difference. The market reacted with a 0.00% price change (close before vs. close after earnings).
Looking ahead to Q1 26, 5 analysts forecast an EPS of 0.15 USD, with revenue projected to reach 271.14 million USD, implying an increase of 7.14% EPS, and increase of 0.27% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Establishment Labs Holdings Inc.
Report Date
May 06, 2026 For Q1 26
Estimate
-$0.35
Actual
-$0.40
Surprise
-12.80%
Progyny, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.30
Actual
$0.50
Surprise
+63.99%
Omada Health, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.08
Actual
$0.01
Surprise
+112.22%
The Oncology Institute, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.02
Surprise
+74.46%
SkinHealth Systems Inc. Class A Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.07
Actual
-$0.05
Surprise
+36.47%
CVS HEALTH CORPORATION
Report Date
May 06, 2026 For Q1 26
Estimate
$2.21
Actual
$2.57
Surprise
+15.80%
Natera, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.54
Actual
-$0.56
Surprise
-2.36%
Viatris Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
$0.51
Actual
$0.59
Surprise
+15.17%
Charles River Laboratories International, Inc.
Report Date
May 07, 2026 For Q1 26
Estimate
$1.96
Actual
$2.06
Surprise
+4.98%
Caris Life Sciences, Inc. Common Stock
Report Date
May 07, 2026 For Q1 26
Estimate
-$0.02
Actual
$0.00
Surprise
+100.00%
FAQ
What were Enhabit, Inc.'s earnings and revenue for the latest quarter Q4 2025?
For Q4 2025, Enhabit, Inc. reported EPS of $0.14, missing estimates by -3.11%, and revenue of $270.40M, -2.02% below expectations.
How did the market react to Enhabit, Inc.'s Q4 2025 earnings?
The stock price moved -- 0%, changed from $13.61 before the earnings release to $13.61 the day after.
When is Enhabit, Inc. expected to report next?
The next earning report is scheduled for May 13, 2026.
What are the forecasts for Enhabit, Inc.'s next earnings report?
Based on 5
analysts, Enhabit, Inc. is expected to report EPS of $0.15 and revenue of $271.14M for Q1 2026.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement